Viacyte

Encellin

The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.

DiogenX

This biotech company develops recombinant proteins designed to regenerate insulin-producing pancreatic beta cells for patients with type 1 diabetes.

Beta Bionics

This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.

VascVersa Ltd

This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.

Zucara Therapeutics

This company develops a drug therapy to prevent hypoglycemia in patients with type 1 diabetes using insulin therapy.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.

Tengion Inc

This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.

StemSight

This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.